APA (7th ed.) Citation

FU, N., M, A., T, K., M, L., A, A., & N, K. (2026). Immune checkpoint inhibitors in advanced cholangiocarcinoma: A systematic review of efficacy, safety, and emerging biomarkers. Journal of the Egyptian National Cancer Institute, 38(1), . https://doi.org/10.1186/s43046-026-00381-8

Chicago Style (17th ed.) Citation

FU, Nisa, Ali M, Khan T, Lohana M, Asif A, and Kumari N. "Immune Checkpoint Inhibitors in Advanced Cholangiocarcinoma: A Systematic Review of Efficacy, Safety, and Emerging Biomarkers." Journal of the Egyptian National Cancer Institute 38, no. 1 (2026). https://doi.org/10.1186/s43046-026-00381-8.

MLA (9th ed.) Citation

FU, Nisa, et al. "Immune Checkpoint Inhibitors in Advanced Cholangiocarcinoma: A Systematic Review of Efficacy, Safety, and Emerging Biomarkers." Journal of the Egyptian National Cancer Institute, vol. 38, no. 1, 2026, https://doi.org/10.1186/s43046-026-00381-8.